DLBCL, DIFFUSED LARGE B CELL LYMPHOMA

Clinical trials for DLBCL, DIFFUSED LARGE B CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new DLBCL, DIFFUSED LARGE B CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for DLBCL, DIFFUSED LARGE B CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists test 'Ready-Made' cell therapy for Tough-to-Treat blood cancers

Disease control Recruiting now

This is an early-stage safety study testing a new type of cell therapy called P-CD19CD20-ALLO1 for adults with aggressive B-cell lymphomas that have come back or not responded to standard treatments. The therapy uses genetically modified immune cells from a donor (not the patient…

Matched conditions: DLBCL, DIFFUSED LARGE B CELL LYMPHOMA

Phase: PHASE1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

DLBCL, DIFFUSED LARGE B CELL LYMPHOMA

Get alerted when new DLBCL, DIFFUSED LARGE B CELL LYMPHOMA trials appear

Scientists test 'Ready-Made' cell therapy for Tough-to-Treat blood cancers